Cargando…
Adjuvant chemotherapy for primary cardiac sarcomas: the IGR experience.
The effect of additional treatments after surgery in patients with primary cardiac sarcoma (PCS) remains unknown. The present study aims to evaluate the benefit of chemotherapy in patients with non-metastatic cardiac sarcomas after optimal resection. Between October 1979 and December 1995, 15 patien...
Autores principales: | Llombart-Cussac, A., Pivot, X., Contesso, G., Rhor-Alvarado, A., Delord, J. P., Spielmann, M., Türsz, T., Le Cesne, A. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group|1
1998
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2063231/ https://www.ncbi.nlm.nih.gov/pubmed/9862574 |
Ejemplares similares
-
New ways and new hopes for IGR development
por: Jindra, Marek
Publicado: (2021) -
The prokaryotic activity of the IGR IRESs is mediated by ribosomal protein S1
por: Roberts, Luc, et al.
Publicado: (2022) -
Methodology for Evaluating the Insect Growth Regulator (IGR) Methoprene on Packaging Films
por: Arthur, Frank H.
Publicado: (2016) -
Bioinformatic evidence for a stem-loop structure 5'-adjacent to the IGR-IRES and for an overlapping gene in the bee paralysis dicistroviruses
por: Firth, Andrew E, et al.
Publicado: (2009) -
Adjuvant Chemotherapy of Soft Tissue Sarcoma—Current Status
por: Judson, Ian
Publicado: (2000)